Accurate identification of patients\' demographic characteristics and case counts are key factors in understanding the pandemic potential of emerging influenza viruses, and the implementation of effective medical surveillance and public health response actions. A recent Editorial in *The Lancet Infectious Diseases* [@bib1] contained an error about the provenance of the first human being with H5N1 avian influenza reported in the western hemisphere, and omitted key data from recent cases of H10N8 avian influenza in human beings in China.

The first confirmed case of H5N1 detected in a human being in the Americas was in a woman, not a man---a hospital health-care worker who died around 1 week after her return to Canada from Beijing, China. The woman, who was travelling with a family member, experienced the first onset of symptoms during her return flight from Beijing to Canada on Dec 27, 2013. She was admitted to hospital on Jan 1, 2014, and died 2 days later on Jan 3.[@bib2], [@bib3] Local media reported that the woman was in her 20s, the age group at highest risk of death from H5N1.[@bib4]

The Editorial cited a fatal case of H10N8 in December, 2013, in a man aged 75 years from China\'s Jiangxi Province. However, two more cases, including a fatality, were reported from China\'s Jiangxi Province between Jan 29, and Feb 13, 2013. The first additional case that ended in a fatality was in a woman aged 73 years, and the second case was a 55-year-old woman.[@bib5], [@bib6] These cases were detected through intensive ongoing surveillance for H7N9 cases in China, which have been most common in elderly people.[@bib4]

The emergence and spread of new viruses should be tracked, and their pandemic potential predicted and countered more readily by the early identification of key, at-risk populations. The high variability of age and sex differences in morbidity and mortality rates from emerging zoonotic viruses, such as new coronaviruses and influenza viruses, can provide important indices of populations at highest risk of infection and death, and insights into potential mechanisms for transmission of these viruses to human beings, and between people. This information, in turn, can help to develop public health strategies for the most efficient and effective use of scarce diagnostic, medical care, and treatment resources.
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